← All trials
NCT02448251
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2015
- Primary completion
- Jan 1, 2018
- Completion date
- Jan 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Acea BioLead sponsor
- University of ColoradoOverall official - principal investigator
- Emory UniversityOverall official - principal investigator
- Wayne State UniversityOverall official - principal investigator
- University of Texas at HoustonStudy director
- City of Hope National Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.